Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
26.74
+0.01 (0.04%)
Feb 21, 2025, 4:00 PM EST - Market closed
Galapagos NV Employees
Galapagos NV had 1,123 employees as of December 31, 2023. The number of employees decreased by 215 or -16.07% compared to the previous year.
Employees
1,123
Change (1Y)
-215
Growth (1Y)
-16.07%
Revenue / Employee
$254,123
Profits / Employee
$68,297
Market Cap
1.77B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
GLPG News
- 2 days ago - Disount To Net Cash For A Promising CAR-T Company - Seeking Alpha
- 5 days ago - Galapagos receives transparency notification and 13D filing from Tang Capital - GlobeNewsWire
- 9 days ago - Galapagos NV (GLPG) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 4 weeks ago - Galapagos To Spin Off Innovative Medicines Business - Forbes
- 6 weeks ago - Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities - GlobeNewsWire
- 6 weeks ago - Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma - GlobeNewsWire